Discovery of 1,3-disubstituted prop-2-en-1-one derivatives as inhibitors of neutrophilic inflammation via modulation of MAPK and Akt pathways
Mohammad Abdel-Halim Dalia S. El-Gamil Mennatallah A. Hammam Mohamed El-Shazly Yi-Hsuan Wang Po-Hsiung Kung Yu-Cheng Chen Michal Korinek Ashraf H. Abadi Matthias Engel Tsong-Long Hwang a Department of Pharmaceutical Chemistry,Faculty of Pharmacy and Biotechnology,German University in Cairo,Cairo,Egyptb Department of Chemistry,Faculty of Pharmacy,Ahram Canadian University,Cairo,Egyptc School of Life and Medical Sciences,University of Hertfordshire Hosted by Global Academic Foundation,Cairo,Egyptd Department of Pharmacognosy,Faculty of Pharmacy,Ain-Shams University,Cairo,Egypte Graduate Institute of Natural Products,College of Medicine,Chang Gung University,Taoyuan,Taiwanf Graduate Institute of Healthy Industry Technology,Research Center for Chinese Herbal Medicine,College of Human Ecology,Chang Gung University of Science and Technology,Taoyuan,Taiwang Graduate Institute of Natural Products,College of Pharmacy,Kaohsiung Medical University,Kaohsiung,Taiwanh Pharmaceutical and Medicinal Chemistry,Saarland University,Saarbrücken,Germanyi Department of Anesthesiology,Chang Gung Memorial Hospital,Taoyuan,Taiwanj Department of Chemical Engineering,Ming Chi University of Technology,New Taipei City,Taiwan
DOI: https://doi.org/10.1080/14756366.2024.2402988
2024-09-21
Journal of Enzyme Inhibition and Medicinal Chemistry
Abstract:Targeting neutrophil function has gained attention as a propitious therapeutic strategy for diverse inflammatory diseases. Accordingly, a series of enone-based derivatives were developed to inhibit neutrophil-mediated inflammation, showing promise for treating inflammatory diseases. These compounds fall into two clusters with distinct effects: one inhibits neutrophilic superoxide (SO) anion production and elastase release triggered by N-formyl-Met-Leu-Phe (fMLF), with compound 6a being most effective (IC 50 values of 1.23 and 1.37 μM, respectively), affecting c-Jun N-terminal kinase (JNK) and Akt phosphorylation. The second cluster suppresses formation of SO anion without affecting elastase levels, surpassed by compound 26a (IC 50 of 1.56 μM), which attenuates various mitogen-activated protein kinases (MAPKs) with minimal Akt impact. Notably, none of the tested compounds showed cytotoxicity in human neutrophils, underscoring their potential as therapeutic agents against inflammatory diseases.
biochemistry & molecular biology,chemistry, medicinal